These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28247579)

  • 1. Effect of habitual exercise on urinary liver-type fatty acid-binding protein levels in middle-aged and older adults.
    Kosaki K; Kamijo-Ikemori A; Sugaya T; Tanahashi K; Sawano Y; Akazawa N; Ra SG; Kimura K; Shibagaki Y; Maeda S
    Scand J Med Sci Sports; 2018 Jan; 28(1):152-160. PubMed ID: 28247579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between exercise capacity and urinary liver-type fatty acid-binding protein in middle-aged and older individuals.
    Kosaki K; Kamijo-Ikemori A; Sugaya T; Tanahashi K; Kumagai H; Sawano Y; Akazawa N; Ra SG; Kimura K; Shibagaki Y; Maeda S
    Clin Exp Nephrol; 2017 Oct; 21(5):810-817. PubMed ID: 28197733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary liver-type fatty acid-binding protein is associated with subendocardial viability ratio in middle- and older-aged adults.
    Kosaki K; Kamijo-Ikemori A; Sugaya T; Tanahashi K; Kumagai H; Sawano Y; Akazawa N; Osuka Y; Tanaka K; Kimura K; Shibagaki Y; Maeda S
    Clin Exp Hypertens; 2018; 40(3):244-250. PubMed ID: 28872349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary liver type fatty acid binding protein in diabetic nephropathy.
    Kamijo-Ikemori A; Sugaya T; Ichikawa D; Hoshino S; Matsui K; Yokoyama T; Yasuda T; Hirata K; Kimura K
    Clin Chim Acta; 2013 Sep; 424():104-8. PubMed ID: 23727660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
    Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
    BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function.
    Przybylowski P; Koc-Zorawska E; Malyszko JS; Kozlowska S; Mysliwiec M; Malyszko J
    Transplant Proc; 2011 Oct; 43(8):3064-7. PubMed ID: 21996226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of urinary liver-type fatty acid binding protein measured by latex-enhanced turbidimetric immunoassay in chronic kidney disease.
    Kamijo-Ikemori A; Sugaya T; Yoshida M; Hoshino S; Akatsu S; Yamazaki S; Kimura K; Shibagaki Y
    Clin Chem Lab Med; 2016 Oct; 54(10):1645-54. PubMed ID: 26943609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Liver Type Fatty Acid Binding Protein Is Negatively Associated With Estimated Glomerular Filtration Rate in Renal Transplant Recipients With Graft Loss.
    Huang YC; Chang YS; Chen CC; Tsai SF; Yu TM; Wu MJ; Chen CH
    Transplant Proc; 2018 May; 50(4):1083-1086. PubMed ID: 29731071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [L-type fatty acid binding protein (L-FABP) and kidney disease].
    Kamijo-Ikemori A; Sugaya T; Kimura K
    Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K
    Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease.
    Kamijo A; Kimura K; Sugaya T; Yamanouchi M; Hikawa A; Hirano N; Hirata Y; Goto A; Omata M
    J Lab Clin Med; 2004 Jan; 143(1):23-30. PubMed ID: 14749682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal expression and urinary excretion of liver-type fatty acid-binding protein in cats with renal disease.
    Katayama M; Ohata K; Miyazaki T; Katayama R; Wakamatsu N; Ohno M; Yamashita T; Oikawa T; Sugaya T; Miyazaki M
    J Vet Intern Med; 2020 Mar; 34(2):761-769. PubMed ID: 32087614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease.
    Kamijo A; Sugaya T; Hikawa A; Yamanouchi M; Hirata Y; Ishimitsu T; Numabe A; Takagi M; Hayakawa H; Tabei F; Sugimoto T; Mise N; Omata M; Kimura K
    Mol Cell Biochem; 2006 Mar; 284(1-2):175-82. PubMed ID: 16532260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of urinary liver-type fatty acid-binding protein with cardiovascular risk factors in the Japanese population without chronic kidney disease: Sasayama study.
    Kubota Y; Higashiyama A; Marumo M; Konishi M; Yamashita Y; Okamura T; Miyamoto Y; Wakabayashi I
    BMC Nephrol; 2021 May; 22(1):189. PubMed ID: 34020611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary fatty acid binding protein as a new clinical marker for the progression of chronic renal disease].
    Kamijo A; Sugaya T; Hikawa A; Kimura K
    Rinsho Byori; 2003 Mar; 51(3):219-24. PubMed ID: 12707994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary liver-type fatty acid-binding protein in pediatric nephrotic syndrome and tubular dysfunction.
    Nishida M; Kawakatsu H; Hamaoka K
    Pediatr Int; 2018 May; 60(5):442-445. PubMed ID: 29460503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice.
    Kosaki K; Sugaya T; Ohata K; Tanabe J; Hoshino S; Inoue K; Kimura K; Maeda S; Shibagaki Y; Kamijo-Ikemori A
    Hypertens Res; 2019 Oct; 42(10):1518-1527. PubMed ID: 31168059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary l-type fatty acid-binding protein is a predictor of early renal function after partial nephrectomy.
    Yanishi M; Kinoshita H; Mishima T; Taniguchi H; Yoshida K; Komai Y; Yasuda K; Watanabe M; Sugi M; Matsuda T
    Ren Fail; 2017 Nov; 39(1):7-12. PubMed ID: 27767358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.